Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THR-100 vs Streptokinase in Acute Myocardial Infarction
NCT01305226Phase 3Completed
- Sponsor
- Bharat Biotech
- Start
- Oct 2010
- Primary completion
- Aug 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of staphylokinase in acute myocardial infarction (AMI), sponsored by Bharat Biotech. Started Oct 2010; status: completed.
02
Drugs
staphylokinase
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT01305226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01305226.